Switzerland· 62957001
Dificlir
A fidaxomicin product containing fidaxomicinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Fidaxomicin is registered in 16 of 19 countries.
Countries holding a registration under ATC A07AA12 (fidaxomicin), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Fidaxomicin · ATC A07AA12
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fidaxomicin costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- Switzerland: $179.87 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Fidaxomicin · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$179.87
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- fidaxomicinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- A07AA12
- ATC class
- Fidaxomicin
- Defined daily dose
- 0.4 g, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768062957001120 StkCHF 1491.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
101 interactions on record for fidaxomicin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fidaxomicin · interactions on record
101 records
- 3 severe
- 24 moderate
- 74 minor
Most severe, free to view
- BerotralstatB06AC06severe
- VenetoclaxL01XX52severe
- RelugolixL02BX04severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fidaxomicin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDificidMerck Sharp & Dohme LLC
- SpainDIFICLIR 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULATillotts Pharma Gmbh
- CzechiaDIFICLIRTillotts Pharma GmbH, Rheinfelden
- SwedenDIFICLIR 200 mg Filmdragerad tablettTillotts Pharma GmbH
- BelgiumDificlir 200 mgTillotts Pharma
- NetherlandsDificlir, 200mg, filmomhulde tablettenTillotts Pharma GmbH
- NorwayDificlirTillotts Pharma GmbH
- PolandDificlirTillotts Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- France · Fidaxomicine Sun
- United Kingdom (Northern Ireland) · Fidaxomicin Tillotts 200 Mg, Fidaxomicin Tillotts 40 Mg/Ml
- Iceland · Dificlir
- Liechtenstein · Dificlir, Dificlir 200 Mg
- Norway · Dificlir, Dificlir 200 Mg
- Sweden · Fidaxomicin Sun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d63c32f-ff01-412c-a41a-54a188b781d0 GET /v1/drugs/3d63c32f-ff01-412c-a41a-54a188b781d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "fidaxomicinum 200 mg",
"valid_from": "2014-10-01",
"limitations": "[{\"description\":\"Zur Behandlung von Clostridium-difficile-assoziierter Diarrhö (CDAD) bei Erwachsenen<br>\\n- Bei Nichtansprechen auf Metronidazol und Vancomycin oder<br>\\n- Bei multiplen Rezidiven (>=2) oder<br>\\n- Zur Nachbehandlung von Patienten, die zuvor stationär mit DIFICLIR behandelt wurden.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2023-02-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 200 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2014-10-01",
"self_retention_pct": 10
}See everything about fidaxomicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.